Macquarie Group’s Rigel Pharmaceuticals RIGL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
|
|||||
|
2024
Q4 | $273 | Buy |
|
|||||
|
2024
Q2 | – | Sell |
|
|||||
|
2024
Q1 | $2.37M | Hold |
|
|||||
|
2023
Q4 | $2.32M | Hold |
|
|||||
|
2023
Q3 | $1.73M | Hold |
|
|||||
|
2023
Q2 | $2.06M | Hold |
|
|||||
|
2023
Q1 | $2.11M | Hold |
|
|||||
|
2022
Q4 | $2.4M | Hold |
|
|||||
|
2022
Q3 | $1.89M | Sell |
|
|||||
|
2022
Q2 | $1.81M | Hold |
|
|||||
|
2022
Q1 | $4.79K | Hold |
|
|||||
|
2021
Q4 | $4.25M | Hold |
|
|||||
|
2021
Q3 | $5.82M | Hold |
|
|||||
|
2021
Q2 | $6.96M | Hold |
|
|||||
|
2021
Q1 | $5.48M | Sell |
|
|||||
|
2020
Q4 | $5.62M | Hold |
|
|||||
|
2020
Q3 | $3.85M | Hold |
|
|||||
|
2020
Q2 | $2.94M | Buy |
|
|||||
|
2020
Q1 | $2.5M | Hold |
|
|||||
|
2019
Q4 | $3.42M | Hold |
|
|||||
|
2019
Q3 | $2.99M | Hold |
|
|||||
|
2019
Q2 | $4.18M | Hold |
|
|||||
|
2019
Q1 | $4.11M | Hold |
|
|||||
|
2018
Q4 | $3.68M | Hold |
|
|||||
|
2018
Q3 | $5.14M | Hold |
|
|||||
|
2018
Q2 | $4.53M | Buy |
|
|||||
|
2018
Q1 | $3.19M | Buy |
|
|||||
|
2017
Q4 | $3.04M | Buy |
|
|||||
|
2017
Q3 | $1.86M | Buy |
|
|||||
|
2017
Q2 | $1.73M | Buy |
|
|||||
|
2017
Q1 | $1.76M | Buy |
|